Manufacturer record
Orchid Biotech Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Orchid Biotech Ltd (Delhi) was declared Not of Standard Quality in September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: OT-250933, Glimepiride, Voglibose & Metformin HCL SR Tablets (exp Jul 2027). SDTL, Andhra Pradesh, Vijayawada (state lab) found it not of standard quality: Assay of Glimepiride. Listed in the September 2026 alert.
Records by type
1 record linked to Orchid Biotech Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Glimepiride, Voglibose & Metformin HCL SR Tablets | Batch OT-250933Mfg Aug 2025 · Exp Jul 2027 | Assay of GlimepirideAssay | SDTL, Andhra Pradesh, VijayawadaState lab | Sep 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.